These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1026526)

  • 1. The effects of disopyramide on the human heart: an electrophysiological study.
    Spurrell RA
    J Int Med Res; 1976; 4(1 Suppl):31-6. PubMed ID: 1026526
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
    Seipel L; Breithardt G; Both A
    Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiological effects of disopyramide on the specialized cardiac conduction system in man (author's transl)].
    Hombach V; Hespe I; Gil-Sanchez D; Freyland MD; Behrenbeck DW; Krüger H; Tauchert M; Hilger HH
    Z Kardiol; 1978 Aug; 67(8):527-33. PubMed ID: 695804
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the acute electrophysiological and cardiovascular action of disopyramide in man.
    Marrott PK; Ruttley MS; Winterbottam JT; Muir JR
    Eur J Cardiol; 1976 Sep; 4(3):303-12. PubMed ID: 964279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods.
    Birkhead JS; Vaughan Williams EM
    Br Heart J; 1977 Jun; 39(6):657-60. PubMed ID: 884018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the effects of quinidine, diphenylhydantoin and disopyramide on the auricular refractory period in the anesthetized dog].
    Duchêne-Marullaz P; Lapalus P; Lavarenne J; Combre A
    Arch Int Pharmacodyn Ther; 1974 Sep; 211(1):150-8. PubMed ID: 4460907
    [No Abstract]   [Full Text] [Related]  

  • 7. Disopyramide: a study of its acute electrophysiological and haemodynamic effects [proceedings].
    Marrott PK; Ruttley MS; Winterbott JT; Muir JR
    Br J Clin Pharmacol; 1975 Aug; 2(4):373P. PubMed ID: 1234005
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electrophysiological action of disopyramide].
    Grosu AA; Malakhov VI; Smetnev AS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):51-5. PubMed ID: 7138657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The electrophysiological effects of disopyramide (author's transl)].
    Ponsonnaille J; Marcheix JC; Gras H
    Ann Cardiol Angeiol (Paris); 1977; 26(2):135-9. PubMed ID: 900834
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrophysiological evaluation of disopyramide in man.
    Josephson ME; Caracta AR; Lau SH; Gallagher JJ; Damato AN
    Am Heart J; 1973 Dec; 86(6):771-80. PubMed ID: 4757788
    [No Abstract]   [Full Text] [Related]  

  • 11. Electrophysiologic effects of disopyramide in children.
    Kashani IA; Shakibi JG; Siassi B
    Jpn Heart J; 1980 Jul; 21(4):491-6. PubMed ID: 7420732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular electrophysiologic changes induced by disopyramide phosphate in normal infarcted hearts.
    Sasyniuk BI; Kus T
    J Int Med Res; 1976; 4(1 Suppl):20-5. PubMed ID: 1026524
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined effect of verapamil and disopyramide on induction of circus movement tachycardia in patients with pre-excitation.
    Matsuda H; Konishi T; Matsuyama E; Tamamura T; Kawai C
    Jpn Circ J; 1981 Oct; 45(10):1138-46. PubMed ID: 7299993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of disopyramide on in vivo measurement of monophasic action potential in canine heart muscle.
    Edwards IR; Martin JF; Ward JW
    J Int Med Res; 1976; 4(1 Suppl):26-30. PubMed ID: 1026525
    [No Abstract]   [Full Text] [Related]  

  • 15. [Electrophysiological interrelations of disopyramide with atropine].
    González Maqueda I; García Fernández F; Martin Jadraque L; López Sendon JL; Coma Canella I
    Rev Esp Cardiol; 1979; 32(2):127-31. PubMed ID: 472418
    [No Abstract]   [Full Text] [Related]  

  • 16. Intracardiac electrophysiological study of disopyramide in intact and chemically sympathectomized dogs.
    Guimond C; Vasseur C; Godin D; Pelletier B; LeBlanc AR; Nadeau R
    Eur Heart J; 1982 Dec; 3(6):553-63. PubMed ID: 7160394
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrophysiology of disopyramide in man.
    Ross D; Vohra J; Cole P; Hunt D; Sloman G
    Aust N Z J Med; 1978 Aug; 8(4):377-83. PubMed ID: 282851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of the antiarrhythmic agent disopyramide phosphate (Norpace).
    Befeler B; Lazzara R
    Heart Lung; 1980; 9(3):475-82. PubMed ID: 6901520
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effect of imolamine, lidocaine and disopyramide on experimental rhythm disorders and auriculoventricular conduction.
    Junien JL; Lakatos CR; Tine J
    Arzneimittelforschung; 1974 Nov; 24(11):1743-7. PubMed ID: 4141258
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of disopyramide on the atrio-ventricular conduction in man. Preliminary results in 13 cases studied by means of recording bundle of His].
    Lotto A; Graziina A; Rota M; Cavallaro GF; Greco EM
    Boll Soc Ital Cardiol; 1973; 18(10):934-6. PubMed ID: 4807027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.